Narcotic analgesics Market

Global Narcotic analgesics Market Size, Share & Trends Analysis Report by Type (Morphine, Fentanyl, and Tramadol) by Application (Hospital, Medical Centre, Others) and Forecast (2021-2027)

Published: Oct 2021 | Report Code: OMR2024273 | Category : Pharmaceuticals | Delivery Format: /

The Global Narcotic analgesics market is estimated to grow at a significant CAGR during the forecast period. Narcotic analgesics are narcotic drugs that primarily act on the central or peripheral nerve systems, selectively inhibiting and alleviating different aches, as well as causing fear and anxiety. It has made a significant contribution to the relief of patient suffering. Anesthesia analgesics, on the other hand, are often used and are easy to become addicted. Drugs containing an opiate pain reliever and at least another analgesic, such as acetaminophen or ibuprofen, are known as narcotic analgesics. When other less potent analgesics are ineffective, they should be used to relieve severe to extreme pain. Narcotic analgesics (also known as, opioid analgesics, sedatives or opiates) work by binding to opioid receptors to relieve severe and chronic pain. Mu, delta, and kappa opioid receptors are the three types.

The global narcotic analgesic medicines market is being driven by an increase in the prevalence of osteoarthritis, back pain, and rheumatoid arthritis. The market for narcotic analgesic medicines is also being driven by an increase in the occurrence of overactive bladder. The market for narcotic analgesic medicines is expected to grow due to an increase in the geriatric population suffering from osteoarthritis pain and the availability of a wide range of over-the-counter pain relievers. The market is expected to be driven by an increase in the elderly population and growing awareness among health professionals about the use of combination drugs, to treat various diseases and infections. The global narcotic market is also growing because to an increase in the incidence of, arthritic pain, neuropathic pain and chronic back pain.

According to the WHO,  in 2019, around 275 million people (or 5.5 percent of the worldwide population aged 15-64) used drugs at least once. Approximately 62 million of them used opioids. In 2019, around 36.3 million people were affected by drug use disorders. The majority of opioid dependent utilised illegally produced and manufactured heroin, but the number of persons who use prescription opioids is increasing.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment covered

o By Type

o By Application

  • Region covered

o Global

  • Competitive Landscape- Sanofi S.A., Endo Pharmaceuticals., GlaxoSmithKline PLC., Pfizer., Reckitt Benckiser., and Novartis AG., among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Market Segmentation

Global Narcotic analgesics market is segmented by Type

o Morphine

o Fentanyl

o Tramadol

Global Narcotic analgesics market is segmented by Application 

o Hospital 

o Medical Center

o Others

Global Narcotic analgesics market is segmented by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa

REQUEST FOR TABLE OF CONTENT